Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep 13;106(10):dju216.
doi: 10.1093/jnci/dju216. Print 2014 Oct.

Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer

Kenneth L Kehl  1 , Neeraj K Arora  1 , Deborah Schrag  1 , John Z Ayanian  1 , Steven B Clauser  1 , Carrie N Klabunde  1 , Katherine L Kahn  1 , Robert H Fletcher  1 , Nancy L Keating  2
Affiliations

Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer

Kenneth L Kehl et al. J Natl Cancer Inst. .

Abstract

Background: Clinical trials are essential to establish the effectiveness of new cancer therapies, but less than 5% of adults with cancer enroll in trials. In addition to ineligibility or lack of available trials, barriers to enrollment may include limited patient awareness about the option of participation.

Methods: We surveyed a multiregional cohort of patients with lung or colorectal cancer (or their surrogates) three to six months after diagnosis. We assessed whether respondents reported learning that clinical trial participation might be an option, and, if so, with whom they discussed trials. We used logistic regression to assess the association of patient characteristics with discussing trial participation and enrolling in trials. All statistical tests were two-sided.

Results: Of 7887 respondents, 1114 (14.1%) reported discussing the possibility of clinical trial participation; most learned about trials from their physicians, and 287 patients (3.6% of all patients, 25.8% of trial discussants) enrolled. Among 2173 patients who received chemotherapy for advanced (stage III/IV lung or stage IV colorectal) cancer, 25.7% discussed trials, and 7.6% (29.5% of trial discussants) enrolled. Discussions were less frequent among older patients, African American or Asian vs white patients, and those with lower incomes and more comorbidity. Enrollment was higher among patients reporting shared vs physician-driven decisions (all P < .05).

Conclusions: In this population-based cohort, only 14% of patients discussed participation in clinical trials. Discussions were more frequent among advanced cancer patients but were still reported by a minority of patients. Strategies to expand access to trials and facilitate patient-provider communication about participation may accelerate development of better cancer therapeutics.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Rates of reported discussions about clinical trials and participation in trials according to management by oncologists.*Two-sided P value for comparison of discussion and participation rates among patients reporting vs not reporting a medical oncologist, based on the chi-square test.
See this image and copyright information in PMC

Comment in

References

    1. Nass SJ, Moses HL, Mendelsohn J. A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine, National Academies Press; 2010:1371. - PubMed
    1. Schroen AT, Petroni GR, Wang H, et al. Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology Groups. Clin Cancer Res. 2012;18(1):256–262 - PMC - PubMed
    1. Fouad MN, Lee JY, Catalano PJ, et al. Enrollment of patients with lung and colorectal cancers onto clinical trials. J Oncol Pract. 2013;9(2):e40–e47 - PMC - PubMed
    1. Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007;14(12):3328–3334 - PubMed
    1. Unger JM, Hershman DL, Albain KS, et al. Patient income level and cancer clinical trial participation. J Clin Oncol. 2013;31(5):536–542 - PMC - PubMed

Publication types

MeSH terms